Evidence map›Paper›PMID 38280871›Full record

ArticleNature communications2024

Cebp1 and Cebpβ transcriptional axis controls eosinophilopoiesis in zebrafish.

Gaofei Li, Yicong Sun, Immanuel Kwok, Liting Yang, Wanying Wen, Peixian Huang, Mei Wu, Jing Li, Zhibin Huang, Zhaoyuan Liu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Gaofei Li *Department of Hematology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China.
Yicong Sun *Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China.
Immanuel KwokSingapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Biopolis, 138648, Singapore.ORCID 0000-0003-1523-1621
Liting YangDepartment of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, P.R. China.
Wanying WenInnovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China.
Peixian HuangInnovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China.
Mei WuInnovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China.
Jing LiInnovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China.
Zhibin HuangInnovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China.ORCID 0000-0003-4286-4002
Zhaoyuan LiuShanghai Institute of Immunology, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China.ORCID 0000-0002-3117-0833
Shuai HeSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China.ORCID 0000-0001-6619-1039
Wan PengSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China.
Jin-Xin BeiSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China.ORCID 0000-0003-1333-407X
Florent GinhouxSingapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Biopolis, 138648, Singapore.ORCID 0000-0002-2857-7755
Lai Guan NgSingapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Biopolis, 138648, Singapore. nglaiguan@renji.com.ORCID 0000-0003-1905-3586
Yiyue ZhangDepartment of Hematology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China. mczhangyy@scut.edu.cn.ORCID 0000-0002-9402-3523
South China University of Technology · CNAgency for Science, Technology and Research · SGSun Yat-sen University · CNSecond Affiliated Hospital of Guangzhou Medical University · CNShanghai Jiao Tong University · CNSouthern Medical University · CN

Funding

Guangzhou Municipal Science and Technology Project 202201010176National Natural Science Foundation of China (National Science Foundation of China) 31922023National Natural Science Foundation of China (National Science Foundation of China) 32100664National Natural Science Foundation of China (National Science Foundation of China) 32100665
6 · The paper itself

Abstract

Eosinophils are a group of granulocytes well known for their capacity to protect the host from parasites and regulate immune function. Diverse biological roles for eosinophils have been increasingly identified, but the developmental pattern and regulation of the eosinophil lineage remain largely unknown. Herein, we utilize the zebrafish model to analyze eosinophilic cell differentiation, distribution, and regulation. By identifying eslec as an eosinophil lineage-specific marker, we establish a Tg(eslec:eGFP) reporter line, which specifically labeled cells of the eosinophil lineage from early life through adulthood. Spatial-temporal analysis of eslec

Indexed as

CCAAT-Enhancer-Binding ProteinsEosinophilsZebrafishAnimalsCCAAT-Enhancer-Binding Protein-betaCell DifferentiationHumansNeutrophilsCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding Proteins

Identifiers

PMID38280871
PMCPMC10821951
OpenAlexW4391276729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.